Tirzepatide 10-Vial Research Kit | HPLC ≥99% | Regena

Tirzepatide combines GLP-1 and GIP receptor activity in a single sequence. The dual agonism is the primary reason it has attracted intense metabolic-research interest over the past several years.

Standard practice mirrors other long-acting GLP-1 research peptides: lyophilised storage at 2–8°C, reconstitution with bacteriostatic water and refrigerated in-use stability of around four weeks.

Each Regena batch publishes an HPLC purity figure and identity confirmation by mass spectrometry. Always cross-check the COA before any quantitative work.

Tirzepatide is available across multiple strengths in the Peptide Library so laboratories can right-size kits to study duration without wasted reconstituted material.